Medy-Tox (XKRX:086900) Total Stockholders Equity : ₩469,463 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Total Stockholders Equity?

Medy-Tox's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩469,463 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Medy-Tox's Book Value per Share for the quarter that ended in Dec. 2023 was ₩69,721.59. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Medy-Tox's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.18.

Medy-Tox Total Stockholders Equity Historical Data

The historical data trend for Medy-Tox's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Total Stockholders Equity Chart

Medy-Tox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

259,147.91

241,397.59

399,481.05

428,044.81

469,462.69

Medy-Tox Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															428,044.81	458,177.39	483,258.35	480,067.53	469,462.69

Medy-Tox (XKRX:086900) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Medy-Tox's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(469462.692	-	220.328)	/	6.73023
	=	69,721.59

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Medy-Tox's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(81604.285	+	1225.842)	/	469462.692
	=	0.18

Medy-Tox Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medy-Tox's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox (XKRX:086900) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox (XKRX:086900) Headlines

No Headlines